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Abstract
 
Immature dendritic cells (iDCs) express the CC chemokine receptor (CCR)5, which promotes
chemotaxis toward the CC chemokines regulated on activation, normal T cell expressed and se-
 
creted (RANTES), macrophage inflammatory protein (MIP)-1
 
a
 
, and MIP-1
 
b
 
. By contrast, ma-
ture DCs downregulate CCR5 but upregulate CXC chemokine receptor (CXCR)4, and as a re-
sult exhibit enhanced chemotaxis toward stromal cell–derived factor (SDF)-1
 
a
 
. CCR5 and
CXCR4 also function as coreceptors for macrophage-tropic (M-tropic) and T cell–tropic (T-
tropic) human immunodeficiency virus (HIV)-1, respectively. Here, we demonstrate chemotaxis
of iDCs toward M-tropic (R5) but not T-tropic (X4) HIV-1. Furthermore, preexposure to
M-tropic HIV-1 or its recombinant envelope protein prevents migration toward CCR5 ligands.
 
The migration of iDCs toward M-tropic HIV-1 may enhance formation of DC–T cell syncytia,
thus promoting viral production and destruction of both DC and T helper lymphocytes. There-
fore, disturbance of DC chemotaxis by HIV-1 is likely to contribute to immunosuppression in pri-
mary infection and AIDS. In addition, migration of iDCs toward HIV-1 may aid the capture of
R5 HIV-1 virions by the abundant DC cell surface protein DC-specific intercellular adhesion mol-
ecule (ICAM)3-grabbing nonintegrin (DC-SIGN). HIV-1 bound to DC cell–specific DC-SIGN
retains the ability to infect replication-permissive T cells in trans for several days. Consequently,
recruitment of DC by HIV-1 could combine with the ability of DC-SIGN to capture and trans-
mit the virus to T cells, and so facilitate dissemination of virus within an infected individual.
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Introduction
 
The dissemination of HIV-1 and establishment of infection
within an individual involves the transfer of virus from mu-
cosal sites of infection to T cell zones in secondary lym-
phoid organs. How this happens is not certain. Once at
these sites, the virus replicates within CD4
 
1
 
 T helper lym-
phocytes and macrophages. The immature dendritic cells
(iDCs) of the skin and mucosa, Langerhans cells (LCs),
have been implicated as the first targets for HIV after sexual
contact (1). In the simian immunodeficiency virus/rhesus
macaque system, the model that most closely resembles
HIV-1 infection in humans, the first cellular targets of in-
fection after vaginal challenge are mucosal DCs (2). The
subsequent appearance of antigen-bearing cells within the
T cell areas of draining lymph nodes (2) has led to the sug-
gestion that DCs may act as “Trojan Horses” (3), carrying
virus to lymph nodes. The proficiency of DCs in interact-
ing with numerous T cells (4) makes them prime candi-
dates for enhancing viral dissemination (5).
iDCs are located in most nonlymphoid tissues, where
they capture and process antigens. After exposure to in-
flammatory signals, they mature and migrate to secondary
lymphoid tissues, where they present antigen to T cells (6).
iDCs express CC chemokine receptor (CCR)5, which en-
ables chemotaxis to the CC chemokines regulated on acti-
vation, normal T cell expressed and secreted (RANTES),
macrophage inflammatory protein (MIP)-1
 
a
 
, and MIP-1
 
b
 
.
Mature DCs downregulate CCR5 but upregulate CXC
chemokine receptor (CXCR)4, and show enhanced chemo-
taxis toward stromal cell–derived factor (SDF)-1 (7). CCR5
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and CXCR4 function as coreceptors for macrophage-
tropic (M-tropic) and T cell–tropic (T-tropic) HIV-1, re-
spectively (8, 9). DCs also express CD4 and are susceptible
to infection by HIV-1 (3). Here, we demonstrate chemo-
taxis of iDCs toward M-tropic (R5) but not T-tropic (X4)
HIV-1. Furthermore, preexposure to M-tropic HIV-1
or its recombinant envelope protein prevents migration
toward CCR5 ligands. These events might play an impor-
tant role in the recruitment of DCs to mucosal sites of
HIV-1 inoculation, and consequently could explain the
dissemination of infection.
 
Materials and Methods
 
Preparation of DCs from Blood and Chemotaxis Assays.
 
Human
DCs were cultured from commercial buffy coats as described pre-
viously (7). Chemotaxis assays are described elsewhere (7). In
brief, 5 
 
3 
 
10
 
4
 
 iDCs in 100 
 
m
 
l culture medium were added to
each 24-well transwell insert (5-
 
m
 
m pores; Costar), with 600 
 
m
 
l
in the lower chamber, with or without chemokine, HIV super-
natant, or recombinant gp120. After 2 h incubation at 37
 
8
 
C, the
transwell inserts were lifted, and the bases were rinsed twice with
200 
 
m
 
l of medium into the lower chamber. Cells in the lower
chamber were collected, transferred into 5-ml U-bottomed clear
tubes, and fixed with 5% formalin. The number of migrating cells
was determined by FACSort™ (Becton Dickinson) as described
previously (7). Results are expressed as the total number of mi-
grating DCs per transwell. Standard deviations are shown for
three or four replicate transwells. Data is representative of at least
three separate experiments.
 
HIV Supernatants.
 
Supernatants of HIV-infected and unin-
fected T cells were separated into concentrate (two times) and fil-
trate by centrifugation through a 100-kD cutoff centricon con-
centrator (Amicon). In all figures the 
 
.
 
100 kD fraction is used as
“supernatant.” Supernatants were quantified for reverse tran-
scriptase (RT) using the Quant-T-RT assay system (Amersham
Pharmacia Biotech). Relative RT units of enzyme by scintillation
proximity assay for unconcentrated supernatants from HIV-1
 
BaL
 
–
infected PM1 cells and HIV-1
 
IIIB
 
–infected H9 cells were 1.4 
 
3
 
10
 
4
 
/ml and 3.9 
 
3
 
 10
 
3
 
/ml, respectively (used in Figs. 1 and 4).
Supernatants of PM1 cells infected with HIV-1
 
BaL
 
 or HIV-1
 
IIIB
 
(relative RT units 2.9 
 
3 
 
10
 
3
 
/ml and 3.3 
 
3 
 
10
 
3
 
/ml) were used in
Fig. 2. For immunoprecipitations, 10 
 
m
 
g of gp120 Ab 2G12, 10
 
m
 
g of gp120 Ab IgG1b12, and 5 
 
m
 
g of gp41 Ab 2F5 (AIDS Re-
agent Project, National Institute for Biological Standards and
Control) were added to 6 ml of BaL viral supernatant or 6 ml of
RPMI plus MIP-1
 
b
 
 as a control. The solutions were mixed on
ice for 30 min before the addition of 20 
 
m
 
g protein A sepharose
(Sigma-Aldrich) in PBS for 45 min. After 45 min of mixing, the
protein A beads were removed by centrifugation. Supernatants
were transferred to another tube, and an additional 20 
 
m
 
g of pro-
tein A sepharose was added. After 45 min, the second protein A
beads were removed, and the supernatants were used for chemo-
taxis assays.
 
Recombinant gp120.
 
DNA encoding gp120 was amplified by
PCR from genomic DNA derived from PM1 cells infected with
HIV-1
 
BaL
 
 and HIV-1
 
ADA 
 
(AIDS Reagent Project, National Insti-
tute for Biological Standards and Control). Primers were de-
signed to extend the COOH terminus with a linker and a FLAG
epitope (EFGGDYKDDDDKGG). The construct was expressed
in Sf9 cells using a p2Bac baculovirus expression system (Invitro-
gen). Cells infected with recombinant viruses secreting gp120
were screened by Western blotting using both anti-FLAG M2
mAb (Sigma-Aldrich) and anti-gp120 mAb (ARP301; National
Institute for Biological Standards and Control). Cell supernatants
were loaded onto an anti-FLAG M2 affinity column (Sigma-
Aldrich) and eluted with pH 3.5 glycine-HCl according to the
manufacturer’s instructions. Purified gp120 was checked by SDS-
PAGE (both reducing and nonreducing) and behaved as a monomer
in gel filtration chromatography. Binding to human CD4 was
confirmed by surface plasmon resonance (BIAcore). Stock solu-
tions of gp120 in Tris-HCl pH 8.0 were diluted into RPMI me-
dia to the required concentration(s). Tris pH 8.0 in RPMI was
used as “medium” control.
 
Results
 
iDCs Exhibit Chemotaxis toward the Supernatant of T Cells
Infected with M-tropic HIV.
 
Monocyte-derived iDCs were
tested in transwell migration assays as described previously
(7). These cells exhibit significant chemotaxis toward
RANTES and the supernatant from T cells infected with
M-tropic HIV-1
 
BaL
 
, but not toward the supernatant from T
cells infected with T-tropic HIV-1
 
IIIB
 
, or from uninfected
cells (Fig. 1). Cell supernatants were separated into concen-
trate (two times) and filtrate by centrifugation through a
100-kD cutoff centricon concentrator (Amicon). In all fig-
ures, the 
 
.
 
100-kD fraction is used as “supernatant.” The
 
.
 
100-kD fraction from HIV-1
 
BaL
 
–infected PM1 cells is
Figure 1. iDCs migrate toward RANTES and M-tropic HIV culture
supernatant but not toward T-tropic HIV or uninfected supernatants. (A)
Chemotaxis of 5 3 104 immatures DCs in a bare transwell migration assay
(described in Materials and Methods). The number of cells migrating into
the lower transwells (31,000) as determined by FACSort™ (Becton
Dickinson) is shown with lower transwells containing medium alone
(RPMI 1640), 6 nM RANTES, supernatant from PM1 T cells alone
(which express CCR5), and PM1 cells infected with M-tropic HIV-1BaL.
Cell supernatants were separated into concentrate (two times) and filtrate
by centrifugation through a 100-kD cutoff centricon concentrator (Ami-
con). In all figures, the .100-kD fraction is used as “supernatant.” The
.100-kD fraction from HIV-1BaL–infected PM1 cells is highly chemo-
tactic, even when added in a 10-fold dilution; this large molecular mass
chemotactic agent is likely HIV-virions/fragments and/or gp120 (see Fig.
3). (B) As in A, except using .100-kD supernatant from H9 T cells in-
fected with the T-tropic HIV-1IIIB. In both graphs, SD from the mean is
shown for four experiments, each with two transwells. Results are repre-
sentative of four experiments 
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highly chemotactic, even when added in a 10-fold dilution;
this large molecular mass chemotactic agent is likely to be
HIV-virions/fragments and/or gp120 (see Fig. 3). Migra-
tion toward the 
 
,
 
100 kD fraction was similar for unin-
fected and HIV-1
 
BaL
 
–infected supernatant, and was only
30% of that toward RANTES (not shown); this small mo-
lecular chemotactic agent is presumed to be a T cell–derived
chemokine(s).
 
Soluble CD4 Increases Chemotaxis toward M-tropic HIV Su-
pernatant.
 
The binding of CD4 to M-tropic HIV envelope
protein (gp120) increases the efficiency of CCR5 binding
(10). Addition of soluble CD4 at 10 
 
m
 
g/ml almost doubled
the chemotactic effect of supernatant from cells infected
with M-tropic virus, without affecting migration toward su-
pernatant from uninfected cells or RANTES (not shown).
 
Anti-HIV Antibodies Remove the Chemotactic Effects of HIV
Supernatant.
 
Immunoprecipitation with anti-HIV anti-
bodies reduced the chemotaxis induced by the supernatant
of PM1 cells infected with HIV-1
 
BaL 
 
to the level induced
by the supernatant from PM1 cells infected by HIV-1
 
IIIB
 
,
suggesting that HIV-1
 
BaL 
 
virions and/or gp120 induce
chemotaxis (Fig. 2).
 
iDCs Migrate toward M-tropic gp120.
 
To confirm that
iDCs migrate toward HIV and rule out a requirement for
M-tropic virus-induced T cell–derived lymphokines, we
examined chemotaxis toward M-tropic recombinant gp120
envelope. iDCs migrate toward M-tropic gp120 from HIV-
1
 
BaL
 
 (Fig. 3 A) and HIV
 
ADA
 
 (Fig. 3 B). By contrast, chemo-
taxis was not observed toward recombinant gp120 from
T-tropic HIV-1
 
IIIB
 
 (Fig. 3 C) or recombinant gp120 from the
T-tropic strains SF2, MN, W61D, and HXB2 (not shown).
Cross-linking of the FLAG-tagged HIV-1
 
BaL
 
 gp120 with
 
anti-FLAG antibody increased its chemotactic potential by
 
z
 
30% (not shown). Treatment of iDCs with anti-CCR5
antibodies prevented migration toward R5 gp120 (Fig. 3
D). Because M-tropic but not T-tropic gp120s induce
chemotaxis, and gp120/CCR5 binding induces an intracel-
lular signal indistinguishable from that of a natural chemo-
tactic ligand (11, 12), we conclude that binding of M-tropic
gp120 to CCR5 can induce DC chemotaxis.
 
Exposure to M-tropic HIV or Its Recombinant Envelope In-
hibits the Response of iDCs to Chemokines.
 
Pretreatment of
iDC for 90 min with 6 nM of the CC chemokines
RANTES (binds CCR1, 3, 4, and 5), MIP-1
 
a
 
 (binds
CCR1 and 5), or MIP-1
 
b
 
 (binds CCR5 and 8) substan-
tially diminishes subsequent chemotactic responses to all
these chemokines, but not to the CXCR4 ligand SDF-1
(not shown). Pretreatment of iDCs with supernatant of T
cells infected with HIV-1
 
BaL
 
, but not the supernatant from
uninfected cells, likewise reduced responses to these CC
chemokines (Fig. 4 A). Conversely, pretreatment of iDCs
with CC chemokines reduced subsequent chemotaxis to-
ward HIV-1
 
BaL
 
 supernatant (not shown). Pretreatment of
iDCs with supernatant from T cells infected with T-tropic
HIV-1
 
IIIB
 
 had no effect on migration toward MIP-1
 
a
 
 or
RANTES (not shown).
Addition of 3 nM M-tropic HIV-1
 
BaL 
 
recombinant
gp120 to the upper transwell (Fig. 4 B) abolished responses
to MIP-1
 
b
 
 at concentrations up to 24 nM. In contrast, simi-
lar pretreatment with recombinant gp120 from the T-tropic
HIV-1
 
IIIB
 
 (1, 6, 24, and 48 nM) was without effect on mi-
gration toward CC chemokines (not shown).
 
Discussion
 
We demonstrate the migration of iDCs toward M-tropic
but not T-tropic HIV-1, and substantiate this finding using
recombinant envelope (gp120) proteins. These observa-
tions have important implications for the establishment,
dissemination, and progression of HIV-1 infection within
an infected individual. HIV Tat has been reported to in-
duce chemotaxis of DCs and monocytes (13, 14). Our re-
sults, which show that the migratory action of HIV-1 is
confined to M-tropic HIV virus, indicate that any chemo-
tactic action of Tat is not apparent in the culture superna-
tant of T cells infected with HIV-1 (Fig. 1 B). We were
unable to observe migration of iDCs toward 10 or 100 nM
basic Tat peptide (amino acids 31–71; reference 14) or a
pool of Tat peptides (amino acids 1–30, 16–45, and 31–71;
data not shown). HIV Nef has been reported to induce ex-
pression of MIP-1
 
a
 
 and MIP-1
 
b
 
 by HIV-1–infected mac-
rophages (15). This induction can mediate the chemotaxis
of lymphocytes (15), and presumably iDCs. Although HIV
Nef–induced CC chemokine production may be responsi-
ble for some CCR5-mediated chemotaxis in our system,
we believe this effect to be insignificant compared with the
direct effects of gp120 for several reasons: (a) an examina-
tion of several viral isolates indicates that the dominant
chemotactic element exhibits M-tropism (R5) specificity;
(b) addition of 10 
 
m
 
g/ml soluble CD4, which enhances the
Figure 2. HIV envelope antibodies reduce the chemotaxis induced by
M-tropic HIV. Immunoprecipitation (IP) of HIV-1BaL supernatant reduces
the induced chemotaxis to the level of HIV-1IIIB supernatant. Similar im-
munoprecipitation of MIP-1b in RPMI resulted in only a 14% decrease in
overall chemotaxis, controlling for general negative effects of either the
antibodies or protein A sepharose. SEM is shown for three transwells. 
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binding of CCR5 to gp120 (10), doubled chemotaxis to-
ward M-tropic viral supernatants without affecting che-
motaxis toward CC chemokines (data not shown); (c) the
difference in chemotaxis induced by supernatant from un-
infected cells and cells infected with T tropic viruses, in-
cluding HIV-1
 
IIIB
 
 that bears Nef, is negligible (data not
shown); (d) immunoprecipitation with anti-HIV envelope
antibodies removes the majority of chemotactic activity
and reduces it to the level induced by HIV-1
 
IIIB
 
 (nef
 
1
 
) su-
pernatant; (e) we show the dominant chemotactic agent to
be 
 
.
 
100 kD; and (f) as recombinant gp120 is active in the
nM region (Fig. 3), there is sufficient envelope protein in
the viral supernatants to account for all the observed
chemotaxis. Supernatants were produced in T cell cultures
at 2–3 
 
3 
 
10
 
6
 
 cells/ml. Each cell need only produce a total
10
 
3
 
 virions during the several days of infection to put the
gp120 concentration (assuming 
 
.
 
200 gp120s/virion) in
the nM range. Detailed studies of supernatants from HIV-
1
 
HXB3
 
–infected T cell cultures are relevant (16, 17). It was
shown that viral supernatants contained 10
 
9
 
–10
 
10
 
 physical
particles/ml. In freshly isolated viral stocks, the ratio of in-
fectious to noninfectious viral particles ranged from 1:10
 
4
 
–
1:10
 
7
 
 (16). HIV-1
 
HXB3
 
 virions spontaneously shed gp120
 
proteins with a half-life of 
 
z
 
30 h (16), and typical viral
stocks were found to have 
 
.0.5 nM soluble gp120 in addi-
tion to virus-associated protein (17). An envelope particle,
consisting of a single envelope spike, contains three gp120s.
The avidity of such a trimeric interaction with CCR5 is
likely to be considerably more than the sum of the individ-
ual affinities. In addition, observations in other systems in-
dicate that higher multimerization of a soluble ligand can
yield a significantly greater intracellular signal (18). Thus,
virions/virion fragments in the supernatants may induce
more chemotaxis than the sum of migration induced by
their individual component gp120 molecules.
iDCs express CCR5 and migrate toward the CC
chemokines RANTES, MIP-1a, and MIP-1b (7). Pre-
formed stores of RANTES (19) are released by CTLs when
they encounter antigen. Activated CTLs also transcription-
ally upregulate MIP-1a and MIP-1b (20). As CTLs are the
only cells capable of recognizing MHC I–restricted antigen,
this chemokine secretion might facilitate the recruitment of
bone marrow–derived APCs, including DCs, into infected
areas (21). M-tropic gp120 is also a ligand for CCR5 and
can generate an intracellular signal similar to that generated
by natural ligands (11, 12). Thus, HIV-1 may exploit the
Figure 3. iDCs migrate toward recom-
binant M-tropic but not T-tropic gp120.
(A) Chemotaxis of iDCs as described in
the legend to Fig. 1 toward baculovirus
expressed recombinant M-tropic gp120
from HIV-1BaL (n 5 3). Migration toward
HIV-1BaL gp120 was observed in 12 exper-
iments. (B) Chemotaxis of iDCs as de-
scribed in the legend to Fig. 1 toward bac-
ulovirus-expressed recombinant M-tropic
gp120 from HIV-1ADA (n 5 3). Data is
representative of four experiments. (C)
Chemotaxis of iDCs as described in the leg-
end to Fig. 1 toward baculovirus-expressed
recombinant T-tropic gp120 from HIV-
1IIIB gp120 (available from the AIDS
Reagent Project, Medical Research
Council, UK). Data is representative of
three experiments. Binding of gp120s to
CD4 was confirmed by surface plasmon
resonance (BIAcore). All graphs show SD
from the mean for three transwells. Similar
results were observed for gp120 from the
T-tropic strains SF2, MN, W61D, and
HXB2. (D) Addition of 1 mg of anti-
CCR5 mAb 2D7 (BD PharMingen) or
45531.111 (R&D Systems) to the transwell
insert inhibits migration to recombinant
HIV-1BaL gp120. Graph shows the SD
from the mean for three replicate trans-
wells. Results are representative of four ex-
periments.591 Lin et al. Brief Definitive Report
migration of iDCs toward CCR5 ligands, and subsequently
to the T cell areas of draining lymph nodes, to aid both the
establishment and dissemination of infection.
HIV-1 is almost entirely M-tropic during primary infec-
tion (22, 23), and the use of coreceptors other than CCR5
by such viruses is rare (24). The iDCs of the skin and mu-
cosa, LCs, have been implicated as the first targets for HIV
after sexual contact (1). In the simian immunodeficiency
virus/rhesus macaque system, the model which most
closely resembles HIV-1 infection in humans, the first cel-
lular targets of infection after vaginal challenge are mucosal
DCs (2). The subsequent appearance of antigen-bearing
cells within the T cell areas of draining lymph nodes (2) has
led to the suggestion that DCs may act as “Trojan Horses”
(3), carrying virus to lymph nodes. Freshly isolated epider-
mal LCs express CCR5 but not CXCR4 on their surface
and fuse with M-tropic but not T-tropic HIV envelopes
(25). If LCs are the first targets of sexually transmitted in-
fection, this may explain why transmission is predominantly
restricted to M-tropic strains (22, 23) and why the resis-
tance to infection is conferred by CCR5 deletion (26, 27).
The recruitment of iDCs along virion gradients toward
infected helper T cells, and vice versa (12, 28, 29), is likely
to lead to the active formation of DC–T cell syncytia. Such
syncytia have been documented in vivo (30) and contribute
to loss of helper T cells (31). Efficient production of HIV-1
requires the synergistic action of the transcription factors
Sp1 and nuclear factor (NF)-kB to drive the HIV-1 pro-
moter (32). Unstimulated T cells express Sp1 but little NF-
kB (33), and so T cell cultures require stimulation by anti-
gen or mitogen to support HIV replication efficiently. In
contrast, DCs constitutively express high levels of all
known NF-kB and Rel proteins, but not Sp1 (33). As a re-
sult, DC–T cell fusion brings together the factors required
for an upregulation of viral transcription, thus transforming
these syncytia into explosive factories for HIV virion pro-
duction. DC–T cell syncytia do not require activation for
efficient virion production (31, 33), and may constitute the
principle source of HIV virions in vivo.
Recent observations showing that a DC surface protein,
DC-specific ICAM3-grabbing nonintegrin (DC-SIGN),
can specifically capture HIV-1 and promote infection in
trans (34) are very relevant to the implications of our obser-
vations. DC-SIGN, a type II membrane protein with an
external mannose-binding, C-type lectin domain, is exclu-
sively and abundantly expressed on the surface of both ma-
ture and immature DCs (35). DC-SIGN is known to bind
to HIV-1 envelope (36). Geijtenbeek et al. (34) have re-
cently demonstrated that DC-SIGN–expressing cells can
retain attached virions in an infectious state for several days
and transmit them to replication-permissive T cells (34).
Indeed, at low virus titer, infection of CD4/CCR5-
expressing cells was not detected without the help of DC-
SIGN in trans (34). Sexual transmission of HIV-1 presum-
ably requires a means for small amounts of virus at mucosal
sites of inoculation to gain access to cells that are permissive
for viral infection. The modulation of iDC chemotaxis by
R5 strains of HIV-1 may enhance the binding of virus to
DC-SIGN in vivo. HIV-1 may then exploit the subse-
quent migration of DCs as they mature to gain access to
the T cell compartment in lymphoid tissues, where it can
replicate and spread freely.
In summary, the recruitment of iDCs toward M-tropic
HIV-1 is likely to assist the establishment of infection by
either increasing the productive infection of iDCs or by
promoting the binding of virions to DC-SIGN. The inhi-
bition of chemotaxis induced by preexposure to M-tropic
HIV-1 (Fig. 4) may result in local arrest of iDCs in vivo.
The proficiency of DCs in recruiting numerous T cells in
lymphoid tissues (4) makes them strong candidates for fur-
ther dissemination of the virus (5). Indeed, the preferential
recruitment and infection of HIV-specific Th cells by anti-
gen-bearing DCs may be instrumental in the preferential
loss of these cells in most patients during primary infection
(37, 38). Thus, the recruitment of iDCs by M-tropic HIV-1
is likely to promote the establishment, dissemination, and
maintenance of HIV-1 infection.
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